Abstract
Primidone (Fig. 1) corresponds chemically to 5-ethyldihydro-5-phenyl-4,6(1-H,5H)pyrimidine-dione with an empirical formula of C12H14N2O2 and a molecular weight of 218.25.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Syversen GB, Morgan JP, Weintraub M, Myers GJ. Acetazolamide-induced interference with primidone absorption. Case reports and metabolic studies. Arch Neurol. 1977;34:80–4.
Battino D, Avanzini G, Bossi L, Croci D, Cusi C, Gomeni C, Moise A. Plasma levels of primidone and its metabolite phenobarbital: effect of age and associated therapy. Ther Drug Monit. 1983;5:73–9.
Theis JGW, Koren G, Daneman R, Sherwin AL, Menzano E, Cortez M, Hwang P. Interactions of clobazam with conventional antiepileptics in children. J Child Neurol. 1997;12:208–13.
Nanda RN, Johnson RH, Keogh HJ, Lambie DG, Melville ID. Treatment of epilepsy with clonazepam and its effect on other anticonvulsants. J Neurol Neurosurg Psychiatry. 1977;40:538–43.
Jawad S, Richens A, Goodwin G, Yuen WC. Controlled trial of lamotrigine (lamictal) for refractory partial seizures. Epilepsia. 1989;30:356–63.
Perucca E, Baltes E, Ledent E. Levetiracetam: absence of pharmacokinetic interactions with other antiepileptic drugs (AEDs). Epilepsia. 2000;41(Suppl):150.
Browne TR, Feldman RG, Buchanan RA, Allen NC, Fawcett-Vickers L, Szabo GK, Mattson GF, Norman SE, Greenblatt DJ. Methsuximide for complex partial seizures: efficacy, toxicity, clinical pharmacology, and drug interactions. Neurology. 1983;33:414–8.
Fincham RW, Schottelius DD, Sahs AL. The influence of diphenylhydantoin on primidone metabolism. Arch Neurol. 1974;30:259–62.
Levy RH, Loiseau P, Guyot M, Blehaut H, Tor J, Moreland TA. Stiripentol kinetics in epilepsy: nonlinearity and interactions. Clin Pharmacol Ther. 1984;36:661–9.
Summary of product characteristics – Sulthiame/Ospolot. 2009.
Doose DR, Walker SA, Pledger G, Lim P, Reife RA. Evaluation of phenobarbital and primidone/phenobarbital (primidone active metabolite) plasma concentrations during administration of add-on topiramate therapy in five multicenter, double-blind, placebo controlled trials in outpatients with partial seizures. Epilepsia. 1995;36 (Suppl 3):158.
Kapetanovic IM, Kupferberg HJ, Porter RJ, Theodore W, Schulman E, Penry JK. Mechanism of valproate–phenobarbital interaction in epileptic patients. Clin Pharmacol Ther. 1981;29:480–6.
Matilainen R, Pitkanen A, Ruutiainen T, et al. Effect of vigabatrin on epilepsy in mentally retarded patients: a 7-month follow-up study. Neurology. 1988;38:743–7.
Schmidt D, Jacob R, Loiseau P, Deisenhammer E, Klinger D, Despland A, Egli M, Basuer G, Stenzel E, Blankenhorn V. Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial. Epilepsy Res. 1993;15:67–73.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag London
About this chapter
Cite this chapter
Patsalos, P.N. (2013). Primidone. In: Antiepileptic Drug Interactions. Springer, London. https://doi.org/10.1007/978-1-4471-2434-4_18
Download citation
DOI: https://doi.org/10.1007/978-1-4471-2434-4_18
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-2433-7
Online ISBN: 978-1-4471-2434-4
eBook Packages: MedicineMedicine (R0)